Celularity Inc share price logo

Celularity Inc Share Price

NASDAQ: CELU

Small Cap

$1.28

+0.03

(+2.40%)

as on

Celularity Inc Stock Performance

as on March 20, 2026 at 6:55 am IST

  • Day's Low

    $1.21
    $1.28
    downward going graph

    5.47%

    Downside

  • 52 Week's Low

    52 Week's High

    $1.01
    $4.35
    downward going graph

    21.09%

    Downside

    239.84%

    Upside

    downward going graph

Celularity Inc share price movements today

Previous Close
$1.25
Open
$1.22
Volume
364.2K
Day's Low - High
$1.21 - $1.28
52 Week Low - High
$1.01 - $4.35

Celularity Inc Historical Returns

1 Month Return
-5.93 %
3 Month Return
-12.41 %
1 Year Return
-26.59 %
3 Year Return
-78.33 %
5 Year Return
0 %

Celularity Inc Stock Fundamentals & Key Indicators

Check Celularity Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$36.0M

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.61%

PE Ratio (TTM)

-0.33

Industry PE ratio

-4.068794117647059

PEG Ratio

0

EBITDA

-41.4M

Revenue (TTM)

40.6M

Profit Margin

-198.75%

Return On Equity TTM

-6367.24%

Celularity Inc Stock Valuation

Track how Celularity Inc P/E has moved over time to understand its valuation trends.

Celularity Inc in the last 5 years

  • Overview

  • Trends

Lowest (-189.67x)

September 30, 2022

Industry (-4.07x)

March 20, 2026

Today (-0.33x)

March 20, 2026

Highest (-0.62x)

June 30, 2025

LowHigh

Today’s Price to Earnings Ratio: -0.33x

Celularity Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Celularity Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Celularity Inc image
Celularity Inc
BUY$36.0MNA-0.33-198.75%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$41.7B115.8%135.118.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$114.7B111.95%29.532.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$32.4BNA114.755.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$78.7B55.68%17.9531.41%

Stock Returns calculator for Celularity Inc Stock including INR - Dollar returns

The Celularity Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Celularity Inc investment value today

Current value as on today

₹81,951

Returns

₹18,049

(-18.05%)

Returns from Celularity Inc Stock

₹26,012 (-26.01%)

Dollar Returns*

₹7,962 (+7.96%)

Analyst Recommendation on Celularity Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Celularity Inc. Average target price of $2.5

Celularity Inc Share Price Target

Get share price movements and forecasts by analysts on Celularity Inc.

What analysts predicted

48.8%UPSIDE

Target Price

$2.5

Current Price

$1.28

Analyzed by

7 Analysts

Target

$2.50

Celularity Inc target price $2.5, a slight upside of 48.8% compared to current price of $1.28. According to 7 analysts rating.

Celularity Inc Stock’s Investor Sentiment and Interest

Search interest for Celularity Inc Stock has increased by 24% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:24% versus previous 30 day period

Celularity Inc Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
2
3
3
14
12
9
18
18
5
5
Gross Profit
2
0
0
13
2
5
10
10
0
3
Operating Income
-42
-16
-99
-7
13
-11
-9
-9
-15
-12
EBITDA
-44
-
-90
-
-8
-12
-
-7
-20
-19
Interest Expense
1
0
0
1
0
1
1
1
1
1
Depreciation
2
2
2
2
1
1
1
1
1
1
Income Before Tax
-47
-93
-93
-22
9
-16
-13
-13
-24
-23
Income Tax Expense
-3
-
2
-
0
-13
-
13
-
0
Net Income
-47
-93
-93
-22
9
-16
-13
-13
-24
-23
Net Profit Margin
-1632.03%
-2479.56%
-2479.56%
-149.94%
78.82%
-173.17%
-73.31%
-73.31%
-427.55%
-436.66%

Celularity Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
17
21
14
21
17
22
54
Gross Profit
10
14
9
11
-1
6
39
Operating Income
0
-264
-151
-109
-25
-76
-38
EBITDA
0
-70
-202
-88
-138
-
-43
Interest Expense
-
3
2
3
3
3
6
Depreciation
-
-
8
8
9
9
7
Income Before Tax
0
-267
-212
-100
14
-196
-57
Income Tax Expense
21
-56
-4
0
0
-
0
Net Income
0
-211
-208
-100
14
-196
-57
Net Profit Margin
-0.01%
-1001.94%
-1458.42%
-469.27%
78.95%
-862.04%
-106.77%

Celularity Inc Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-93
-93
-22
9
-16
-13
-13
-24
-23
Operating Cash Flow
-8
-8
-4
-4
0
1
1
0
-4
Investing Cash Flow
-
0
-
0
0
-
-1
-
2
Financing Cash Flow
5
5
6
0
0
0
0
1
3
Change in Cash
-2
-2
1
-4
0
0
0
0
0

Celularity Inc Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
5
-208
-100
14
-196
-57
Operating Cash Flow
-1
-63
-110
-137
-38
-6
Investing Cash Flow
-286
-12
-5
-5
-
0
Financing Cash Flow
288
102
98
119
24
6
Change in Cash
0
26
-17
-23
-18
0

Global Institutional Holdings in Celularity Inc

Funds
Holdings
Northern Trust Corp
0.12%
Tower Research Capital LLC
0.02%
Royal Bank of Canada
0.06%
Perennial Investment Advisors, LLC
0.05%
Geode Capital Management, LLC
0.48%
See all

Insights on Celularity Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -24.52M → -23.07M (in $), with an average increase of 6.3% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, CELU stock has moved up by 4.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 65.9% return, outperforming this stock by 144.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 22.7% return, outperforming this stock by 49.3%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 18.13M → 5.28M (in $), with an average decrease of 38.1% per quarter

About Celularity Inc

Celularity, Inc. headquartered in Florham Park, N.J., is a clinical stage biotechnology company leading the next evolution in cellular medicine by developing off-the-shelf placental-derived allogeneic cell therapies, including unmodified natural killer (NK) cells, genetically-modified NK cells, T-cells engineered with a CAR (CAR T-cells), and mesenchymal-like adherent stromal cells (ASCs) targeting indications across cancer, infectious and degenerative diseases. In addition, Celularity develops and manufactures innovative biomaterials also derived from the postpartum placenta. Celularity believes that by harnessing the placenta’s unique biology and ready availability, it will be able to develop therapeutic solutions that address significant unmet global needs for effective, accessible, and affordable therapies.
OrganisationCelularity Inc
Headquarters170 Park Avenue, Florham Park, NJ, United States, 07932
IndustryHealthcare
CEODr. Robert Joseph Hariri M.D., Ph.D.
E-voting on sharesClick here to vote

Key Management of Celularity Inc

Name

Title

Mr. John R. Haines

Senior EVP, Corporate Secretary, Global Manager & Chief Administrative Officer

John Sprague

Acting Chief Financial Officer

Mr. Carlos Ramirez

SVP of Investor Relations

Dr. Stephen A. Brigido D.P.M.

President of Degenerative Diseases

Sharmila Koppisetti M.D.

Senior Vice President of Clinical Dev. Immunology & Drug Safety

Mr. Tim Wilk

Senior Vice President of Technical Operations

Mr. David Jakob Lemus CPA, M.S., MBA

Treasurer

Dr. Robert Joseph Hariri M.D., Ph.D.

Founder, CEO & Chairman

FAQs

What is Celularity Inc share price today?

Celularity Inc share price today is $1.28 as on at the close of the market. Celularity Inc share today touched a day high of $1.28 and a low of $1.21.

What is the 52 week high and 52 week low for Celularity Inc share?

Celularity Inc share touched a 52 week high of $4.35 on and a 52 week low of $1.01 on . Celularity Inc stock price today i.e. is closed at $1.28,which is 70.57% down from its 52 week high and 26.73% up from its 52 week low.

What is Celularity Inc's market capitalisation today?

Celularity Inc market capitalisation is $0.00T as on .

How to invest in Celularity Inc Stock (CELU) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Celularity Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Celularity Inc Shares that will get you 1.1719 shares as per Celularity Inc share price of $1.28 per share as on March 20, 2026 at 1:25 am IST.

What is the minimum amount required to buy Celularity Inc Stock (CELU) from India?

Indian investors can start investing in Celularity Inc (CELU) shares with as little as ₹93.193 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹931.93 in Celularity Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Celularity Inc share’s latest price of $1.28 as on March 20, 2026 at 1:25 am IST, you will get 7.8125 shares of Celularity Inc. Learn more about fractional shares .